An Open-Label, Phase 1b Trial to Assess the Safety and Efficacy of ST316 in Participants With Familial Adenomatous Polyposis (FAP) | MicrobiomeTrials← Back to trialsNCT07729371
An Open-Label, Phase 1b Trial to Assess the Safety and Efficacy of ST316 in Participants With Familial Adenomatous Polyposis (FAP)
RecruitingPHASE1INTERVENTIONAL
Trial Details
Start: 2027-01-04Est. Completion: 2028-12-31
Enrollment target: 40 participants Other microbiome trials you might be interested in
Familial Adenomatous Polyposis (FAP)Pouches, Ileoanal
This international, multi-centre randomised controlled trial will compare dye-based chromoendoscopy with virtual chromoe…
London, United KingdomEst. completion Jul 9, 2031
CancerColorectal CancerSolid TumorLocally Advanced Solid TumorMetastatic CancerWNT PathwayHCCDesmoidMicrosatellite Stable Colorectal Cancer
Metastatic Castration-resistant Prostate Cancer
Familial Adenomatous Polyposis (FAP)
Endometrial Carcinoma
Prostate Cancer
Microsatellite Instability-High Colorectal Cancer
Adamantinomatous Craniopharyngioma
The goal of this clinical trial is to determine if FOG-001 is safe and effective in participants with locally advanced o…
Phoenix, United StatesEst. completion Apr 1, 2027